SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-19-021556
Filing Date
2019-10-30
Accepted
2019-10-30 20:02:31
Documents
1
Period of Report
2019-10-25

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 7354
  Complete submission text file 0001213900-19-021556.txt   8673
Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address
Mattes Glenn R. (Reporting) CIK: 0001568678 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39102 | Film No.: 191181616

Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Issuer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations